fr
Article scientifique
Anglais

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study

Publié dansLancet oncology, vol. 15, no. 9, p. 931-942
Date de publication2014
Résumé

More effective treatments have become available for haematological malignancies from the early 2000s, but few large-scale population-based studies have investigated their effect on survival. Using EUROCARE data, and HAEMACARE morphological groupings, we aimed to estimate time trends in population-based survival for 11 lymphoid and myeloid malignancies in 20 European countries, by region and age.

Mots-clés
  • Adolescent
  • Adult
  • Aged
  • Cause of Death
  • Cohort Studies
  • Combined Modality Therapy
  • Confidence Intervals
  • Disease-Free Survival
  • Europe
  • Female
  • Hematologic Neoplasms/diagnosis/mortality/therapy
  • Humans
  • Male
  • Middle Aged
  • Registries
  • Retrospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Survival Analysis
  • Young Adult
Citation (format ISO)
SANT, Milena et al. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. In: Lancet oncology, 2014, vol. 15, n° 9, p. 931–942. doi: 10.1016/S1470-2045(14)70282-7
Fichiers principaux (1)
Article (Published version)
accessLevelRestricted
Identifiants
ISSN du journal1470-2045
651vues
1téléchargements

Informations techniques

Création16.12.2014 13:20:00
Première validation16.12.2014 13:20:00
Heure de mise à jour14.03.2023 22:36:24
Changement de statut14.03.2023 22:36:23
Dernière indexation16.01.2024 15:37:57
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack